SHL Telemedicine Stock

SHL Telemedicine ROA 2024

SHL Telemedicine ROA

-0.06

Ticker

SHLTN.SW

ISIN

IL0010855885

WKN

589969

In 2024, SHL Telemedicine's return on assets (ROA) was -0.06, a 8,998.11% increase from the -0 ROA in the previous year.

SHL Telemedicine Aktienanalyse

What does SHL Telemedicine do?

SHL Telemedicine Ltd is a leading company in the field of telemedicine solutions and was founded in Israel in 1987. The company develops, produces, and distributes medical equipment and software applications to offer remote monitoring services for various industries. The company started as a pioneer in the telemedicine industry, manufacturing devices for remote monitoring of high blood pressure and diabetes. Today, the company offers a wide range of telemedicine devices and solutions that allow patients and medical professionals to maintain control over their health and medical data. SHL Telemedicine operates on a global level and has expanded its presence in various advanced countries, including Europe, North America, and the Asia-Pacific region. The company has also had strategic partnerships with various international organizations and governments to spread its telemedicine solutions worldwide. Business Model: The company operates under a business-to-business model and provides a range of cost-effective and high-quality telemedicine solutions for various industries, including life sciences, health technology, financial services, government organizations, and insurance. SHL Telemedicine offers its customers products and services related to remote monitoring, tele-diagnosis, teleconsultation, and patient management. The company's solutions are versatile and aim to improve the quality of healthcare and reduce costs. Products and Services: The company offers a wide range of products and services aimed at improving healthcare and providing medical professionals, patients, and decision-makers with improved control over their health. Some of the company's most well-known products and services include: 1. CardioSTAT: A solution for remote monitoring of heart patients 2. DiabetesSTAT: A device for remote monitoring of diabetes patients 3. GraB: A device for monitoring and treating sleep disorders 4. Carenet: A platform for tele-diagnosis and teleconsultation 5. SHL Connect: A platform that allows patients to track their health data online 6. eXzellenZ: A platform that enables medical professionals and doctors to provide remote monitoring services SHL Telemedicine is committed to offering a comprehensive and flexible range of telemedicine products and services to improve healthcare worldwide. The company aims to enhance patients' quality of life, increase the efficiency of medical care, and promote cost savings in the healthcare industry. SHL Telemedicine ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding SHL Telemedicine's Return on Assets (ROA)

SHL Telemedicine's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing SHL Telemedicine's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider SHL Telemedicine's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in SHL Telemedicine’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about SHL Telemedicine stock

What is the Return on Assets (ROA) of SHL Telemedicine this year?

The Return on Assets (ROA) of SHL Telemedicine is -0.06 undefined this year.

What was the ROA of SHL Telemedicine compared to the previous year?

The ROA of SHL Telemedicine has increased by 8,998.11% compared to the previous year.

What consequences do high ROA have for investors of SHL Telemedicine?

A high ROA is advantageous for investors of SHL Telemedicine, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in SHL Telemedicine?

A low ROA can be unfavorable for investors of SHL Telemedicine as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of SHL Telemedicine affect the company?

An increase in ROA of SHL Telemedicine can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of SHL Telemedicine impact the company?

A reduction in the ROA of SHL Telemedicine can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of SHL Telemedicine?

Some factors that can influence the ROA of SHL Telemedicine include revenue, operating costs, asset structure, and industry average.

Why is the ROA of SHL Telemedicine important for investors?

The ROA of SHL Telemedicine is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can SHL Telemedicine take to improve ROA?

To improve ROA, SHL Telemedicine can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does SHL Telemedicine pay?

Over the past 12 months, SHL Telemedicine paid a dividend of 1 USD . This corresponds to a dividend yield of about 36.63 %. For the coming 12 months, SHL Telemedicine is expected to pay a dividend of 0 USD.

What is the dividend yield of SHL Telemedicine?

The current dividend yield of SHL Telemedicine is 36.63 %.

When does SHL Telemedicine pay dividends?

SHL Telemedicine pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of SHL Telemedicine?

SHL Telemedicine paid dividends every year for the past 0 years.

What is the dividend of SHL Telemedicine?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is SHL Telemedicine located?

SHL Telemedicine is assigned to the 'Health' sector.

Wann musste ich die Aktien von SHL Telemedicine kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of SHL Telemedicine from 4/16/2019 amounting to 1 USD, you needed to have the stock in your portfolio before the ex-date on 4/10/2019.

When did SHL Telemedicine pay the last dividend?

The last dividend was paid out on 4/16/2019.

What was the dividend of SHL Telemedicine in the year 2023?

In the year 2023, SHL Telemedicine distributed 0 USD as dividends.

In which currency does SHL Telemedicine pay out the dividend?

The dividends of SHL Telemedicine are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von SHL Telemedicine

Our stock analysis for SHL Telemedicine Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SHL Telemedicine Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.